Comments
Loading...

Oncology Institute Analyst Ratings

TOINASDAQ
Logo brought to you by Benzinga Data
$3.06
0.072.34%
At close: -
$3.07
0.010000.33%
After Hours: 7:58 PM EDT
Q1 2025 Earnings were released on Wed May 14th, after the market close
The most recent conference call was at 17:00 PM, 5 days ago Click to view past webcast
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$2.00
Consensus Price Target1
$4.83

Oncology Institute Analyst Ratings and Price Targets | NASDAQ:TOI | Benzinga

The Oncology Institute Inc has a consensus price target of $4.83 based on the ratings of 3 analysts. The high is $10 issued by Jefferies on August 15, 2022. The low is $2 issued by Guggenheim on June 16, 2023. The 3 most-recent analyst ratings were released by Jefferies, Guggenheim, and Guggenheim on February 26, 2024, June 16, 2023, and March 20, 2023, respectively. With an average price target of $2.5 between Jefferies, Guggenheim, and Guggenheim, there's an implied -18.57% downside for The Oncology Institute Inc from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Jefferies
Guggenheim
Jefferies

1calculated from analyst ratings

Analyst Ratings for Oncology Institute

Buy NowGet Alert
02/26/2024Buy Now-18.57%Jefferies
Jack Slevin37%
→ $2.5Assumes → BuyGet Alert
06/16/2023Buy Now-34.85%Guggenheim
Sandy Draper73%
$3 → $2MaintainsBuyGet Alert
03/20/2023Buy Now-2.28%Guggenheim
Sandy Draper73%
$6 → $3MaintainsNeutralGet Alert
11/11/2022Buy Now95.44%Guggenheim
Sandy Draper73%
$7 → $6MaintainsBuyGet Alert
08/15/2022Buy Now225.73%Jefferies
Brian Tanquilut46%
→ $10Initiates → BuyGet Alert

FAQ

Q

What is the target price for Oncology Institute (TOI) stock?

A

The latest price target for Oncology Institute (NASDAQ:TOI) was reported by Jefferies on February 26, 2024. The analyst firm set a price target for $2.50 expecting TOI to fall to within 12 months (a possible -18.57% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Oncology Institute (TOI)?

A

The latest analyst rating for Oncology Institute (NASDAQ:TOI) was provided by Jefferies, and Oncology Institute their buy rating.

Q

When was the last upgrade for Oncology Institute (TOI)?

A

There is no last upgrade for Oncology Institute

Q

When was the last downgrade for Oncology Institute (TOI)?

A

There is no last downgrade for Oncology Institute.

Q

When is the next analyst rating going to be posted or updated for Oncology Institute (TOI)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Oncology Institute, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Oncology Institute was filed on February 26, 2024 so you should expect the next rating to be made available sometime around February 26, 2025.

Q

Is the Analyst Rating Oncology Institute (TOI) correct?

A

While ratings are subjective and will change, the latest Oncology Institute (TOI) rating was a with a price target of $0.00 to $2.50. The current price Oncology Institute (TOI) is trading at is $3.07, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch